Table 4.

Tenascin-C transcript levels in carcinomas stratified by age

		Number of molecules			Mean
Age	Sample	Total TNC	TNC-AD1	TNC-AD2	Total TNC	TNC-AD1	TNC-AD2
≤40 years	T1	1,212,265	52,620	0	143,696,985	8,944,007	2,027,925
	T2	99,024,132	1,567,084	0	(P = 0.005)	(P = 0.030)
	T3	2,088,668	150,030	118,774
	T4	958,188	58,137	0
	T5	4,701,400	0	0
	T6	14,962,216	0	0
	T7	11,837,854	197,415	0
	T8	339,673	0	0
	T9	192,103,000	17,251,715	11,618,505
	T10	1,100,396,396	79,107,073	10,569,893
	T11	153,043,046	0	0
>40 years	T12	37,859,646	0	0	4,677,309	25,914	2,211
	T13	208,821	37,702	24,325
	T14	7,992,309	0	0
	T15	66,360	7,451	0
	T16	897,614	0	0
	T17	73,244	0	0
	T18	1,206,237	229,110	0
	T19	168,882	9,045	0
	T20	276,036	0	0
	T21	6,970	1,746	0
	T22	2,694,279	0	0

Normalised expression of tenascin-C (TNC) molecules in carcinomas from women aged ≤40 years and >40 years. Mann-Whitney tests were used to calculate P values.